A detailed history of North Rock Partners, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, North Rock Partners, LLC holds 3,890 shares of NVO stock, worth $553,819. This represents 0.04% of its overall portfolio holdings.

Number of Shares
3,890
Previous 2,756 41.15%
Holding current value
$553,819
Previous $285,000 75.09%
% of portfolio
0.04%
Previous 0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

BUY
$102.11 - $135.92 $115,792 - $154,133
1,134 Added 41.15%
3,890 $499,000
Q4 2023

Feb 08, 2024

SELL
$87.78 - $105.45 $2,194 - $2,636
-25 Reduced 0.9%
2,756 $285,000
Q3 2023

Oct 24, 2023

BUY
$90.94 - $199.54 $252,904 - $554,920
2,781 New
2,781 $252,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $321B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track North Rock Partners, LLC Portfolio

Follow North Rock Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of North Rock Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on North Rock Partners, LLC with notifications on news.